Answers are grounded in this paper and cite their sources.
Rational design: A series of 2-aroxyl-1,2,4-triazolo[1,5-c]pyrimidine derivatives were computationally designed (see scheme) and synthesized as conformationally flexible AHAS inhibitors. These compounds could find use as new leads for combating drug resistance.
No takes yet. Share an insight, caveat, or question.
Ji et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: